Columbia Laboratories (CBRX) –
-
Form 8-K JUNIPER PHARMACEUTICALS For: Apr 10
-
Form 8-K COLUMBIA LABORATORIES For: Apr 02
-
Columbia Laboratories, Inc. to Become Juniper Pharmaceuticals, Inc.
-
Form 8-K COLUMBIA LABORATORIES For: Mar 27
-
Columbia Laboratories Acquires Exclusive Worldwide License to a Novel Segmented Intra-vaginal Ring Delivery Technology
-
Form 8-K COLUMBIA LABORATORIES For: Mar 18
-
Columbia Laboratories (CBRX) Misses Q4 EPS by 12c
-
Form 10-K COLUMBIA LABORATORIES For: Dec 31
-
Columbia Laboratories Reports Fourth Quarter and Full-Year 2014 Financial Results
-
Trading Radar for 3/18: FedEx (FDX), General Mills (GIS), Jabil Circuit (JBL), Renren (RENN), E-House (EJ) Report
-
Federal Appeals Court Affirms Dismissal of Class Action Lawsuit
-
Columbia Laboratories to Discuss Fourth Quarter and Full Year 2014 Financial Results on March 18th Conference Call
-
Form 4 COLUMBIA LABORATORIES For: Feb 11 Filed by: Patel Nikin
-
Form 4 COLUMBIA LABORATORIES For: Feb 11 Filed by: CONDELLA FRANK JR
-
Form 8-K COLUMBIA LABORATORIES For: Jan 28
-
Columbia Laboratories (CBRX) Chairman to Retire; Reports Amendment to Increase Permissible Ownership Levels Under Shareholder Rights Plan
-
Form 8-K COLUMBIA LABORATORIES For: Jan 09
-
Form 4 COLUMBIA LABORATORIES For: Jan 06 Filed by: Martell Bridget A
-
Form 4 COLUMBIA LABORATORIES For: Nov 20 Filed by: HUNTER DONALD H
-
Form 10-Q COLUMBIA LABORATORIES For: Sep 30
-
Form 8-K COLUMBIA LABORATORIES For: Oct 28
-
Pre-Open Stock Movers 10/28: (RCPT) (TRNX) (VDSI) (MSG) Higher; (TWTR) (AMKR) (CVLT) Lower (more...)
-
Columbia Laboratories (CBRX) Tops Q3 EPS by 22c
-
Form 4 COLUMBIA LABORATORIES For: Oct 01 Filed by: Elston George
-
Form 8-K COLUMBIA LABORATORIES For: Sep 23
-
Columbia Laboratories (CBRX) Completes CRINONE Renewal in Key Market
-
Columbia Laboratories (CBRX) CEO Buys 10K Shares
-
Form 4 COLUMBIA LABORATORIES For: Aug 13 Filed by: CONDELLA FRANK JR
-
Form 8-K COLUMBIA LABORATORIES For: Aug 06
-
Form 10-Q COLUMBIA LABORATORIES For: Jun 30
-
Form 8-K COLUMBIA LABORATORIES For: Jul 31
-
Columbia Laboratories, Inc. (CBRX) Reports Q1 EPS of $0.01
-
Columbia Laboratories, Inc. (CBRX) Reports Q4 EPS of $0.08; Guides
-
Columbia Labs (CBRX) Issues Strong Prelim. Q4, FY13 Numbers
-
Columbia Laboratories (CBRX) CEO Makes Small Insider Buy
-
Columbia Laboratories, Inc. (CBRX) Tops Q3 EPS by 4c
-
Columbia Labs (CBRX) Acquires Molecular Profiles in $25M Deal
-
Columbia Laboratories, Inc. (CBRX) Tops Q2 EPS by 1c
-
Columbia Laboratories, Inc. (CBRX) Misses Q1 EPS by 2c
-
Columbia Labs (CBRX) Extends License, Supply Agreement for Crinone
-
Columbia Laboratories, Inc. (CBRX) Tops Q4 EPS Views by 50%
-
Trading Radar for 03/14: Kirkland's (KIRK), Aeropostale (ARO), Buckle (BKE), Molycorp (MCP) Report
-
Columbia Labs (CBRX) Extends Expiration of Rights Plan
-
Columbia Laboratories, Inc. (CBRX) Misses Q3 EPS by 1c
-
Unusual 11 Mid-Day Movers 10/26: (AMCC) (DV) (TASR) Higher; (CBRX) (CTCT) (MXWL) Lower
-
Columbia Labs (CBRX) Confirms FDA Denies Watson's (WPI) Appeal on Prochieve
-
Columbia Laboratories (CBRX) trading halted with news pending
-
Unusual 11 Mid-Day Movers 10/24: (SEH) (AMRS) (FB) Higher; (TPX) (IRBT) (NSM) Lower
-
Unusual 11 Mid-Day Movers 09/21: (HALO) (KERX) (SNSS) Higher; (PEIX) (BTH) (KBH) Lower
-
Columbia Laboratories (CBRX) Regains NASDAQ Compliance
Back to CBRX Stock Lookup